Michael Kahn Selected Research

TCF Transcription Factors

4/2013	γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.
7/2011	Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression.
8/2010	Inhibition of Wnt/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis.
8/2005	Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Kahn Research Topics

Disease

23	Neoplasms (Cancer) 06/2022 - 05/2005
6	Fibrosis (Cirrhosis) 01/2021 - 08/2010
5	Colonic Neoplasms (Colon Cancer) 06/2014 - 08/2004
4	Nasopharyngeal Carcinoma 06/2022 - 04/2015
4	Inflammation (Inflammations) 01/2015 - 02/2002
4	Asthma (Bronchial Asthma) 11/2003 - 02/2002
3	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2011
3	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2011
3	Disease Progression 01/2020 - 05/2009
3	Carcinogenesis 03/2018 - 01/2014
3	Leukemia 01/2018 - 08/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2011
3	Wounds and Injuries (Trauma) 03/2017 - 04/2013
3	Colorectal Neoplasms (Colorectal Cancer) 06/2014 - 05/2009
3	Edema (Dropsy) 05/2005 - 02/2002
2	Liver Neoplasms (Liver Cancer) 01/2022 - 04/2013
2	Pain (Aches) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 03/2017 - 11/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 08/2011
2	Hepatocellular Carcinoma (Hepatoma) 07/2014 - 04/2013
2	Lung Injury 03/2013 - 01/2012
2	Idiopathic Pulmonary Fibrosis 12/2012 - 01/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2012 - 08/2010
2	Eosinophilia 11/2002 - 02/2002
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Tics (Tic) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Triple Negative Breast Neoplasms 12/2018
1	Adenocarcinoma 03/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2018
1	Hypoventilation 03/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Parkinsonian Disorders (Parkinsonism) 05/2015
1	Glioma (Gliomas) 05/2015
1	Proteinuria 01/2015
1	Wilms Tumor (Wilm's Tumor) 01/2015
1	Hepatoblastoma 07/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2013
1	Infarction (Infarctions) 01/2013
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2012
1	Kidney Diseases (Kidney Disease) 09/2011
1	Ureteral Obstruction 09/2011
1	Residual Neoplasm 08/2011
1	Atherosclerosis 07/2011
1	Myocardial Infarction 09/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2010

Drug/Important Bio-Agent (IBA)

29	CateninsIBA 06/2022 - 02/2011
12	ICG 001IBA 06/2022 - 08/2004
6	Pharmaceutical PreparationsIBA 01/2021 - 08/2011
6	beta CateninIBA 08/2010 - 08/2004
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2005
4	SurvivinIBA 03/2018 - 05/2005
4	TCF Transcription FactorsIBA 04/2013 - 08/2005
3	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2012
3	CollagenIBA 01/2016 - 09/2011
3	Fibronectins (Fibronectin)IBA 11/2015 - 07/2011
3	NF-kappa B (NF-kB)IBA 05/2005 - 11/2002
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2003
2	Estrogen ReceptorsIBA 01/2021 - 01/2011
2	Carrier Proteins (Binding Protein)IBA 03/2018 - 08/2010
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 03/2018 - 08/2010
2	LigandsIBA 01/2016 - 05/2009
2	CREB-Binding ProteinIBA 11/2013 - 08/2010
2	Biological ProductsIBA 04/2013 - 03/2008
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2012 - 08/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2009 - 05/2005
2	Interleukin-4 (Interleukin 4)IBA 02/2003 - 02/2002
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 02/2003 - 11/2002
2	Interleukin-13IBA 11/2002 - 02/2002
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	PlatinumIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	Gemcitabine FDA Link 03/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	NexusIBA 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 05/2015
1	Cisplatin (Platino)FDA LinkGeneric 04/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	NPHS2 proteinIBA 01/2015
1	nephrinIBA 01/2015
1	Coloring Agents (Dyes)IBA 01/2014
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2012
1	Conditioned Culture MediaIBA 01/2012
1	Plasminogen Activator Inhibitor 1IBA 09/2011
1	Inhibitor of Apoptosis ProteinsIBA 08/2011
1	Small Interfering RNA (siRNA)IBA 08/2011
1	coactivator-associated arginine methyltransferase 1IBA 05/2011
1	gamma Catenin (Plakoglobin)IBA 02/2011
1	Doxycycline (Periostat)FDA LinkGeneric 01/2011
1	Estrogens (Estrogen)FDA Link 01/2011
1	CaspasesIBA 09/2010

Therapy/Procedure

11	Therapeutics 01/2021 - 09/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 08/2011
1	Pain Management 01/2020
1	Immunotherapy 01/2019
1	Laryngoscopes 03/2017
1	Airway Management 03/2017